AMA Update Tuesday, Congressional leaders released a health care package to accompany the FY 2025 Continuing Resolution that is supposed to be voted on by December 20. Here is a document that highlights the key provisions of interest to medicine. In…
Allergy Comments on 2019 Proposed PFS
The Advocacy Council of the American College of Allergy, Asthma and Immunology (ACAAI) together with its sponsoring organization, the ACAAI, the American Academy of Allergy, Asthma and Immunology (AAAAI), and the American Academy of Otolaryngic Allergy (AAOA) submitted comments on the proposed changes to the physician fee schedule rule for 2019 as published in the July 27, 2018 Federal Register.
Our comments focus on four issues: (1) the cost of venom antigens used in treating allergies to stinging insects (CPT Codes 95145-95149); (2) the proposal to reduce the supply cost for inhalant antigens used in allergen immunotherapy (CPT Codes 95144 and 95165); (3) the proposed change in the allergy/immunology indirect practice cost index (IPCI) resulting from the consolidation of evaluation and management (E&M) office visit codes and the creation of a 2 separate “specialty” for E&M office visits; and (4) the multiple procedure payment reduction (MPPR) policy.
Comments were successfully uploaded to the CMS site. View the final document here.
